Breast-cancer adjuvant therapy with zoledronic acid

N Engl J Med. 2012 Jan 12;366(2):188-9; author reply 189. doi: 10.1056/NEJMc1113049.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans

Substances

  • Bone Density Conservation Agents
  • Diphosphonates